Spread the love

Dysregulation of Non-Coding RNAs in Age-Related Neurodegenerative Diseases

Non-coding RNAs (ncRNAs) are a class of RNA molecules that do not code for proteins but play crucial roles in various cellular processes. Dysregulation of ncRNAs has been implicated in the pathogenesis of age-related neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease.

Alzheimer’s Disease

In Alzheimer’s disease, dysregulation of ncRNAs, such as microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), has been observed in the brain tissue of affected individuals. These dysregulated ncRNAs can influence the expression of genes involved in key processes, such as amyloid-beta production, tau phosphorylation, and neuroinflammation, which are hallmarks of Alzheimer’s disease.

See also How does magnesium contribute to stress reduction?

Parkinson’s Disease

Similarly, dysregulation of ncRNAs has been implicated in Parkinson’s disease. Studies have shown altered expression of miRNAs and lncRNAs in the brains of Parkinson’s disease patients. These dysregulated ncRNAs can affect the expression of genes involved in mitochondrial dysfunction, protein aggregation, and oxidative stress, which are key factors contributing to the neurodegeneration observed in Parkinson’s disease.

Huntington’s Disease

In Huntington’s disease, dysregulation of ncRNAs has also been observed. Altered expression of miRNAs and lncRNAs has been detected in the brains of Huntington’s disease patients. These dysregulated ncRNAs can impact the expression of genes involved in mutant huntingtin protein toxicity, mitochondrial dysfunction, and excitotoxicity, which are central to the pathogenesis of Huntington’s disease.

See also What are the economic implications of pension system demographic changes?

In summary, the dysregulation of ncRNAs, including miRNAs and lncRNAs, contributes to age-related neurodegenerative diseases by influencing the expression of genes involved in key pathological processes. Understanding the role of ncRNAs in these diseases may provide insights into potential therapeutic targets for intervention and treatment.

Keywords: disease, ncrnas, dysregulation, expression, parkinson, huntington, diseases, alzheimer, mirnas